In the Nifty 50 index, 41 stocks ended in the green, while 9 stocks closed in the red in today's trade. This is to inform that pursuant to the SEBI(PIT) Regulations 2015 and the companies code of ...

ADELAIDE, Australia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, a global contract research organization focused on accelerating clinical development for biotech sponsors, today announced the ...

Avance Technologies has signed a non-binding term sheet to acquire up to 100% equity stake in Pushpak AI, a Hyderabad-based company specializing in Computer Vision and Edge AI platforms. The move ...

Avance Technologies has signed a non-binding term sheet to acquire upto 100% equity stake in Pushpak AI, a Hyderabad-based Computer Vision and Edge AI platform. The announcement comes amid rapid ...

Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...

Avance Biosciences has opened a 75,000-square-foot biomanufacturing facility in Northwest Houston. The facility will support the production of cell and gene therapies, vaccines, and other biologic ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...

(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of ...

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...